Search 33,000+ CME courses
Back

University of Kentucky Healthcare CE Central

  • HIV Infections

REPRIEVE Trial What Does it Mean for Providers and Patients?

Upon completion of this activity, participants will be able to: 1. Describe elevated cardiovascular risk in persons with HIV 2. Define main results of the REPRIEVE trial 3. Identify implications of the REPRIEVE trial for primary prevention of cardiovascular disease in persons with HIV

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.75 creditsDentistryUp to 0.75 creditsNursingUp to 0.75 creditsPharmacyUp to 0.75 creditsSocial WorkUp to 0.75 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 0.75 credits
  • Released
    Jun 1, 2024
  • Last day to claim credit
    Jun 2, 2027 8 months left

Related courses

See all

Other providers’ courses on the same topic

More from University of Kentucky Healthcare CE Central

See all

This provider’s courses closest to this one